Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE

v3.21.2
NET LOSS PER SHARE
9 Months Ended
Sep. 30, 2021
NET LOSS PER SHARE  
NET LOSS PER SHARE

22. NET LOSS PER SHARE

The Company computes basic loss per share using net loss attributable to Common Stockholders and the weighted-average number of Common Stock shares outstanding during each period. Diluted earnings per share include shares issuable upon exercise of outstanding stock options and stock-based awards where the conversion of such instruments would be dilutive.

Three Months Ended September 30, 

Nine Months Ended September 30, 

(in thousands, except per share amounts)

    

2021

    

2020

    

2021

    

2020

Numerator for basic and diluted net loss per share:

  

 

  

  

 

  

Net loss attributable to Common Stockholders

$

(66,879)

$

(19,457)

$

(169,167)

$

(65,027)

Denominator for basic and diluted net loss per share:

 

  

 

  

 

  

 

  

Weighted-average shares

 

260,556

 

159,968

 

251,468

 

158,121

Net loss per share—Basic and Diluted

$

(0.26)

$

(0.12)

$

(0.67)

$

(0.41)

The Company’s potential dilutive securities, which include outstanding Common Stock options, unvested restricted stock units, unvested restricted stock awards and outstanding Common Stock warrants, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding as of September 30, 2021 and 2020, from the computation of diluted net loss per share attributable to common stockholders because including them would have an anti-dilutive effect (in thousands):

Nine Months Ended September 30, 

2021

    

2020

Common Stock options outstanding

14,500

12,964

Unvested restricted stock units outstanding

8,311

Unvested restricted stock awards outstanding

348

1,317

Common Stock warrants outstanding

619

Total shares

23,159

14,900